Aetna’s President of Medicare: MA Plans Go All-In on Aging in Place with New 2024 Benefits, Palliative Care, Hospice VBID

Aetna, a subsidiary of CVS Health (NYSE: CVS), is leveraging a series of new benefits that, coupled with existing palliative care programs and ongoing hospice payment demonstrations, promise to keep patients in their homes and out of facilities. The new benefits are heavily focused on making medications affordable and addressing social determinants of health. Beneficiaries […]

Hospice M&A ‘Historically Strong’ Despite Recent Cool Down

Though investors and strategic buyers didn’t wade quite as deep into the hospice market in 2022 compared to years prior, the tide may be rising for M&A during 2023. Though hospice M&A activity fluctuated last year, volume is expected to rebound, but probably with larger numbers of smaller deals. Swelling demand for hospice and home […]

Smaller Deals Likely to Reign in 2023 Hospice M&A

Though buyers remain hungry for hospice acquisitions, smaller deals will likely be the most prevalent during 2023. Acquisition patterns established in 2021 and 2022 are shaping the M&A outlook for the current year. The number of hospice and home health deals fell by nearly a third last year, though a few “megadeals” have driven up […]

Quality Data Crucial for Hospices in Value-Based Reimbursement

Understanding payer priorities in defining the scope of quality is vital for hospices to thrive not only in traditional Medicare, but also in today’s value-based reimbursement climate. The nitty gritty details of data tracking and management matter when it comes to ensuring both a healthy bottom line and quality patient care. This includes performance on […]